UX-DA001

· Shanghai UniXell Biotechnology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UX-DA001, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease [Phase 1]